The popularity of Sildenafil initially sparked a boom for the drug industry, but recent developments present a murky outlook for shareholders. Off-patent versions are reducing revenue, and continued patent challenges https://ronaldnwny986791.blogchaat.com/41466909/viagra-and-the-pharmaceutical-industry-a-risky-bet